Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Aalborg Fysioterapi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   1.0% 0.9% 1.0% 1.2% 0.8% 0.9% 6.2% 5.8%   Credit score (0-100)   88 89 87 81 91 89 38 40   Credit rating   A A A A AA A BBB BBB   Credit limit (kDKK)   366.7 410.9 364.7 154.6 726.1 718.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   8,086 8,819 8,583 9,565 11,069 10,859 0.0 0.0   EBITDA   1,764 2,006 1,382 946 2,368 1,882 0.0 0.0   EBIT   1,065 1,343 623 123 1,551 1,095 0.0 0.0   Pre-tax profit (PTP)   1,049.0 1,355.6 623.0 141.8 1,613.5 1,260.2 0.0 0.0   Net earnings   818.0 1,057.2 490.3 127.5 1,257.9 982.3 0.0 0.0   Pre-tax profit without non-rec. items   1,049 1,356 623 142 1,613 1,260 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,330 2,063 1,790 1,782 1,291 1,018 0.0 0.0   Shareholders equity total   4,045 3,602 3,982 3,996 5,140 6,004 5,832 5,832   Interest-bearing liabilities   0.0 0.0 555 450 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,550 6,036 6,195 5,607 6,299 6,594 5,832 5,832   Net Debt   -520 -230 259 437 -1,383 -1,205 -5,007 -5,007     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   8,086 8,819 8,583 9,565 11,069 10,859 0.0 0.0   Gross profit growth   19.3% 9.1% -2.7% 11.4% 15.7% -1.9% -100.0% 0.0%   Employees   16 16 17 19 19 19 0 0   Employee growth %   6.7% 0.0% 6.3% 11.8% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,550 6,036 6,195 5,607 6,299 6,594 5,832 5,832   Balance sheet change%   1.8% 8.8% 2.6% -9.5% 12.4% 4.7% -11.5% 0.0%   Added value   1,764.0 2,005.6 1,381.7 946.3 2,374.4 1,882.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,196 -156 -1,357 -1,157 -1,633 -1,387 -1,018 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.2% 15.2% 7.3% 1.3% 14.0% 10.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   19.4% 23.4% 10.5% 2.6% 27.4% 19.7% 0.0% 0.0%   ROI %   25.2% 33.5% 15.2% 3.4% 34.0% 22.7% 0.0% 0.0%   ROE %   22.6% 27.6% 12.9% 3.2% 27.5% 17.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   72.9% 59.7% 64.3% 71.3% 81.6% 91.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -29.5% -11.5% 18.8% 46.2% -58.4% -64.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 13.9% 11.3% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.1% 0.0% 6.3% 2.6% 7.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.2 0.8 1.1 1.3 3.1 7.6 0.0 0.0   Current Ratio   1.2 0.8 1.1 1.3 3.1 7.6 0.0 0.0   Cash and cash equivalent   520.0 230.4 295.5 12.7 1,383.1 1,204.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   293.0 -518.9 155.6 504.0 2,463.9 3,907.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   110 125 81 50 125 99 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   110 125 81 50 125 99 0 0   EBIT / employee   67 84 37 6 82 58 0 0   Net earnings / employee   51 66 29 7 66 52 0 0